> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Posts 10 OMB Comment Request Notices
- URL: https://www.fdaweb.com/fda-posts-10-omb-comment-request-notices/
- Published: 2017-03-15T12:00:00.000Z
- Updated: 2026-09-14T22:11:53.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138202

*Federal Register* Notices: FDA has posted 10 Office of Management and Budget information collection notices, nine of them health product-focused, that have been backlogged and now released after a regulatory review by the Trump administration. The nine are:

- Comment Request: Testing Communications on Medical Devices and Radiation-Emitting Products. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-15/pdf/2017-05097.pdf?ref=fdaweb.com).
- Comment Request: Recommended Glossary and Educational Outreach To Support Use of Symbols on Labels and in Labeling of *In Vitro* Diagnostic Devices Intended for Professional Use. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-15/pdf/2017-05106.pdf?ref=fdaweb.com).
- Comment Request: Food and Drug Administration Safety Communication Readership Survey. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-15/pdf/2017-05103.pdf?ref=fdaweb.com).
- Comment Request: Focus Groups About Drug Products as Used by the Food and Drug Administration. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-15/pdf/2017-05099.pdf?ref=fdaweb.com).
- Comment Request: Guidance for Industry on Expedited Programs for Serious Conditions-Drugs and Biologics. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-15/pdf/2017-05104.pdf?ref=fdaweb.com).
- Comment Request: Safety Assurance Case. In 2011, FDA announced its intention to evaluate the use of assurance cases as part of its Plan of Action to strengthen the 510(k) program following the publication of a draft guidance on infusion pumps. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-15/pdf/2017-05095.pdf?ref=fdaweb.com).
- Comment Request: Guidance for Industry on Special Protocol Assessment. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-15/pdf/2017-05098.pdf?ref=fdaweb.com).
- Comment Request: Guidance for Industry on Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-15/pdf/2017-05100.pdf?ref=fdaweb.com).
- Comment Request: Medical Devices; Pediatric Uses of Devices; Requirement for Submission of Information on Pediatric Subpopulations That Suffer From a Disease or Condition That a Device Is Intended To Treat, Diagnose, or Cure. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-15/pdf/2017-05096.pdf?ref=fdaweb.com).